Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Katrien Pletinckx, Martin Vaeth, Theresa Schneider, Niklas Beyersdorf, Thomas Hünig, Friederike Berberich-Siebelt, Manfred B Lutz
Index: Eur. J. Immunol. 45(2) , 480-91, (2015)
Full Text: HTML
Abstract
Anergic T cells can survive for long time periods passively in a hyporesponsive state without obvious active functions. Thus, the immunological reason for their maintenance is unclear. Here, we induced peptide-specific anergy in T cells from mice by coculturing these cells with immature murine dendritic cells (DCs). We found that these anergic, nonsuppressive IL-10(-) Foxp3(-) CTLA-4(+) CD25(low) Egr2(+) T cells could be converted into suppressive IL-10(+) Foxp3(-) CTLA-4(+) CD25(high) Egr2(+) cells resembling type-1 Treg cells (Tr1) when stimulated a second time by immature DCs in vitro. Addition of TGF-β during anergy induction favored Foxp3(+) Treg-cell induction, while TGF-β had little effect when added to the second stimulation. Expression of both CD28 and CTLA-4 molecules on anergic T cells was required to allow their conversion into Tr1-like cells. Suppressor activity was enabled via CD28-mediated CD25 upregulation, acting as an IL-2 sink, together with a CTLA-4-mediated inhibition of NFATc1/α activation to shut down IL-2-mediated proliferation. Together, these data provide evidence and mechanistical insights into how persistent anergic T cells may serve as a resting memory pool for Tr1-like cells. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Related Compounds
Related Articles:
P2X receptors regulate adenosine diphosphate release from hepatic cells.
2014-12-01
[Purinergic Signal. 10(4) , 587-93, (2014)]
Myeloid Sirtuin 2 Expression Does Not Impact Long-Term Mycobacterium tuberculosis Control.
2015-01-01
[PLoS ONE 10 , e0131904, (2015)]
2014-01-01
[PLoS ONE 9(7) , e101881, (2014)]
Trabecular bone loss in collagen antibody-induced arthritis.
2015-01-01
[Arthritis. Res. Ther. 17 , 189, (2015)]
2015-03-01
[Clin. Exp. Immunol. 179(3) , 529-38, (2015)]